CUE
Cue Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$36.53
−3.46%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$2.24
- Revenue estimate
- $1.0M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$24
- EPS estimate
- -$1.69
- Revenue actual
- $7.9M
- Revenue estimate
- $3.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -300.1%
- Revenue beats (12Q)
- 7
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$1.69 | -$24 | Miss -1328.40% | $7.9M |
| May 14, 2026 | -$3.30 | -$1.08 | Beat 67.27% | $5.7M |
| Nov 12, 2025 | -$0.10 | -$0.07 | Beat 30.00% | $2.1M |
| Aug 12, 2025 | -$0.13 | -$0.09 | Beat 30.77% | $3.0M |
| Mar 31, 2025 | -$0.16 | -$0.13 | Beat 18.75% | $1.6M |
| Nov 14, 2024 | -$0.20 | -$0.17 | Beat 15.00% | $3.3M |
| Aug 14, 2024 | -$0.29 | -$0.20 | Beat 31.03% | $2.7M |
| May 9, 2024 | -$0.30 | -$0.25 | Beat 16.67% | $1.7M |
| Nov 9, 2023 | -$0.30 | -$0.24 | Beat 20.00% | $2.1M |
| Mar 21, 2023 | -$0.32 | -$0.37 | Miss -15.62% | $151.2K |
| Nov 14, 2022 | -$0.38 | -$0.31 | Beat 18.42% | $68.0K |
| Aug 4, 2022 | -$0.42 | -$0.37 | Beat 11.90% | $26.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026